Drug Addiction and Overdose Prevention

• • NOTOC**

Drug Addiction and Overdose Prevention

Overdose Deaths and a Fragile Decline

Drug overdose remains one of the most serious public-health crises in the United States and other countries. After years of rapidly increasing mortality, overdose deaths began declining substantially. United States data showed a major decrease during 2024 and another decline during 2025, marking several consecutive years of improvement. Canada also reported declining drug-toxicity deaths.

The reduction in deaths represents significant progress, but public-health specialists warn against assuming that the overdose emergency has ended. Tens of thousands of people continue to die each year, and mortality remains far above levels recorded before the COVID-19 pandemic.

The reasons for declining deaths are still being studied. Possible contributors include wider naloxone availability, expanded addiction treatment, community outreach, changes in fentanyl potency or availability, opioid-settlement investments, improved surveillance, and changes in drug-use patterns. Progress is also uneven among states, racial groups, rural communities, and economically marginalized populations.

A decline in overdose deaths can quickly reverse if treatment, prevention, naloxone distribution, surveillance, or recovery programs are reduced. Maintaining the downward trend requires sustained investment rather than declaring the crisis solved.

Naloxone and Emergency Overdose Response

Naloxone is a medication that rapidly blocks the effects of opioids and can restore breathing during an opioid overdose. The expansion of over-the-counter naloxone nasal sprays has allowed the medication to be sold without an individual prescription and stocked in pharmacies, schools, workplaces, libraries, correctional facilities, and community organizations.

Signs of an opioid overdose may include unconsciousness, slowed or stopped breathing, choking or gurgling sounds, limpness, discolored lips, and pinpoint pupils. A suspected overdose requires immediate action. Naloxone should be administered, emergency services should be contacted, and rescue breathing should be provided when appropriate.

Additional naloxone doses may be required because powerful synthetic opioids can remain active longer than the overdose-reversal medication. A person who regains consciousness should still receive emergency medical care.

Families, friends, caregivers, service workers, and community members can learn to recognize an overdose and administer naloxone. Public naloxone cabinets, vending machines, distribution programs, and community boxes increasingly place the medication in locations where it can be obtained quickly.

Cost, stigma, limited pharmacy participation, unequal distribution, and insurance barriers still prevent some people from obtaining naloxone. Public-health strategies therefore emphasize placing overdose medication directly in communities with high overdose risk.

A nonfatal overdose should also be treated as an urgent opportunity to connect a person with continuing care. Emergency departments and other health providers can offer naloxone, assess for substance-use disorder, initiate medication treatment, evaluate mental-health risks, and establish direct connections to recovery services.

Evidence-Based Addiction Treatment and Recovery

Addiction is a treatable chronic medical condition. Repeated drug exposure can alter brain systems associated with reward, judgment, stress, and self-control, but treatment and long-term support can help people reduce substance use and maintain recovery.

Methadone, buprenorphine, and naltrexone are evidence-based medications for opioid-use disorder. Methadone reduces withdrawal and cravings and is associated with lower mortality when patients remain in consistent treatment. Buprenorphine also reduces cravings and withdrawal and can be prescribed in many medical settings. Naltrexone blocks opioid effects but normally requires patients to complete opioid withdrawal before treatment begins.

Primary-care clinics, emergency departments, correctional facilities, and telehealth programs can all play a role in addiction treatment. Beginning buprenorphine in an emergency department after an overdose or during withdrawal can immediately connect a patient with ongoing care.

Treatment retention is especially important. Relapse does not necessarily mean that treatment has failed. As with other chronic medical conditions, treatment plans may need to be adjusted when symptoms return or circumstances change.

Recovery often requires more than medication or counseling. Stable housing, employment, transportation, education, family support, physical health care, peer services, and protection from discrimination can strongly influence whether a person remains connected to treatment.

Peer-support workers with lived recovery experience can help people navigate services, establish goals, develop trust, and remain engaged in care. Recovery-oriented systems seek to combine clinical treatment with these broader social and community supports.

Co-occurring mental-health conditions should be treated alongside substance-use disorders. Depression, trauma, anxiety, and suicide risk can increase overdose vulnerability and interfere with recovery when they are not addressed.

Harm Reduction and Safer-Use Strategies

Harm reduction seeks to prevent death and disease while keeping people connected with services, including people who are not currently able or willing to stop using drugs.

Fentanyl test strips can identify fentanyl in many drug samples. Drug checking can give people information that allows them to avoid a substance, use a smaller amount, avoid using alone, or ensure naloxone is available.

Syringe-service programs reduce the transmission of infectious diseases and often provide sterile equipment, naloxone, testing, vaccinations, wound care, and treatment referrals. These programs may become trusted points of contact between people who use drugs and health professionals.

Drug analysis can also detect xylazine, carfentanil, novel opioids, contaminants, and unexpected changes in potency. Rapid warnings about changing drug supplies allow communities to distribute naloxone and alert people at greatest risk.

Remote overdose-monitoring services provide another prevention tool. A person can contact a trained operator before using drugs. When the person becomes unresponsive, the service can request emergency assistance.

Harm-reduction programs have increasingly appeared at music festivals and other public settings. Organizations may distribute naloxone, teach overdose response, provide drug checking, and educate participants about contaminated substances.

Harm reduction remains politically contested. Some policymakers favor abstinence-focused or enforcement-oriented strategies and have restricted funding for test strips or syringe programs. Public-health advocates argue that these interventions save lives and create opportunities for people to eventually enter treatment.

Fentanyl and Emerging Drug-Supply Threats

The unpredictable illicit drug supply is a major driver of overdose deaths. Illicit fentanyl may be mixed with heroin, cocaine, methamphetamine, or counterfeit pills. People consuming these substances may have no knowledge that fentanyl is present or how much they are receiving.

Counterfeit pills can resemble legitimate pain or anxiety medications while containing potentially lethal quantities of fentanyl. Drugs purchased outside licensed pharmacies therefore carry substantial risk.

Carfentanil presents an additional threat. This extremely potent synthetic opioid has reappeared in parts of the illicit supply and has been associated with hundreds of deaths.

Xylazine is also increasingly detected with fentanyl. It can cause profound sedation, slowed breathing, and severe wounds. Naloxone should still be administered when opioid exposure is suspected, but naloxone does not directly reverse xylazine.

Polysubstance use further complicates overdose prevention. Opioids combined with alcohol or benzodiazepines can severely suppress breathing. Cocaine and methamphetamine may be contaminated with fentanyl or used together with opioids, creating unpredictable medical emergencies.

Drug markets change quickly. A decline in fentanyl potency or availability may have contributed to falling overdose deaths in some areas, but new substances, trafficking patterns, and contaminants can rapidly create new overdose clusters.

Surveillance and Early Warning Systems

Timely information is essential for preventing overdose deaths. Traditional mortality statistics may take months to complete, making faster surveillance systems increasingly important.

Real-time overdose mapping allows health departments and public-safety agencies to identify sudden clusters, coordinate community outreach, investigate dangerous drug supplies, and distribute naloxone.

Anonymous text-alert systems can warn residents about fentanyl, counterfeit pills, unusual overdose activity, or contaminated substances. These alerts encourage people to carry naloxone, test drugs, and take additional precautions.

Researchers are also exploring artificial intelligence and clinical language models to identify substances mentioned in medical-examiner records. Faster analysis could improve the detection of emerging drugs and overdose patterns.

Social-media language, wastewater surveillance, emergency department information, and other data sources may also provide early signals of changes in drug consumption.

Social and economic information can help identify communities at increased risk before mortality rises dramatically. Disability, transportation problems, poor health, inadequate treatment availability, unstable housing, and other conditions may indicate where prevention resources are urgently needed.

Prevention, Prescribing, and Community Protection

No single intervention can end the overdose crisis. Effective prevention combines safer prescribing, early intervention, addiction treatment, naloxone, harm reduction, surveillance, recovery services, public education, and strategies addressing social conditions.

Prescription drug monitoring programs can help clinicians identify overlapping prescriptions, dangerous medication combinations, and multiple prescribers. These findings should support careful evaluation rather than automatic dismissal of patients from care.

Medications should be stored securely to prevent accidental poisoning and diversion. Unused controlled drugs can be taken to authorized collection locations and national drug take-back events.

Youth substance-use prevention should begin before addiction develops. Strong families, supportive schools, positive relationships, reduced trauma, social connection, and early mental-health care can strengthen protective factors and delay substance use.

Schools are increasingly developing naloxone policies and training nurses, teachers, coaches, and other employees to respond to suspected overdoses.

Workplaces can also stock naloxone and create recovery-friendly employment policies. Confidential treatment referrals, employee assistance, supervisor education, and supportive return-to-work practices can reduce stigma and help people remain employed during recovery.

Libraries have become important overdose-prevention partners in many communities. Some libraries provide naloxone, staff training, peer outreach, social workers, and connections to treatment and housing services.

Health Equity and Social Conditions

Overdose risk is shaped by more than individual drug use. Housing instability, poverty, trauma, isolation, transportation barriers, discrimination, and lack of access to health care can increase vulnerability.

People experiencing homelessness or unstable housing may find it difficult to store medication, attend treatment appointments, maintain communication with providers, or avoid using drugs alone.

Rural communities face additional barriers, including long travel distances, shortages of health professionals, limited methadone programs, inadequate broadband, and slower emergency response.

Overdose deaths have disproportionately affected some Black, American Indian, Alaska Native, rural, and economically marginalized communities. Effective programs should therefore be locally designed and culturally appropriate.

Stigma is another major barrier. Language that defines people by drug use can discourage treatment and influence health professionals and policymakers. Person-first language, such as "person with a substance-use disorder," recognizes addiction as a medical condition rather than a personal identity.

Pregnant people with opioid-use disorder generally require continuing evidence-based treatment. Medical guidance supports medications such as methadone or buprenorphine rather than abrupt withdrawal, which can increase relapse and overdose risk.

Adolescents also require age-appropriate treatment, early screening, mental-health support, overdose education, naloxone, and access to effective medications when medically appropriate.

Incarceration and High-Risk Transitions

The period following release from jail or prison is associated with particularly high overdose risk. Reduced opioid tolerance, interrupted treatment, unstable housing, and limited access to health care can contribute to fatal overdoses.

Correctional facilities can reduce these risks by providing addiction medications, naloxone, overdose education, peer navigation, and reentry planning before release.

California correctional facilities have expanded naloxone access for incarcerated people and staff. Similar programs seek to ensure that people leaving correctional facilities have overdose-reversal medication and direct connections to continuing treatment.

Diversion programs may also connect people with treatment instead of jail. Overdose diversion, arrest diversion, and reentry case management can potentially reduce deaths when participants are successfully connected to effective services.

Government Policy and Funding

Federal, state, and local governments fund addiction prevention, treatment, recovery programs, surveillance, and overdose response. Major federal investments have supported mental-health programs, workforce development, first-responder training, and community addiction services.

National drug strategies frequently combine prevention, recovery, treatment, naloxone, drug testing, law enforcement, and border-security policies. Disagreements remain over the proper balance between public health and criminal enforcement.

Changes in federal policy have created concern about restrictions on fentanyl test strips, syringe services, and other harm-reduction programs. Public-health organizations warn that reducing funding during a period of declining overdose deaths could reverse recent gains.

Opioid litigation settlements have provided billions of dollars to state and local governments. Public-health specialists recommend using these funds to expand evidence-based prevention, treatment, recovery, and overdose response rather than replacing existing health budgets.

Investigations have found that some governments used settlement money for routine expenses or law-enforcement equipment only indirectly related to addiction. Greater transparency and public oversight are therefore important.

Geographic differences also influence policy. States and communities with limited treatment capacity, high transportation costs, or growing fentanyl problems may require different combinations of services and funding.

Community Partnerships and Comprehensive Systems

Successful overdose prevention often depends on cooperation between health departments, hospitals, treatment providers, harm-reduction programs, law enforcement, first responders, schools, libraries, employers, and community organizations.

Health departments can combine overdose surveillance with rapid outreach. When clusters are identified, agencies can warn residents, increase naloxone distribution, expand drug checking, and connect people with treatment.

Public-health and public-safety partnerships can improve the sharing of overdose information, but prevention programs also require community trust. People who use drugs may avoid services when they fear arrest, discrimination, or loss of housing.

Good Samaritan laws in many states provide limited legal protections for people who call emergency services during an overdose. The scope of these protections varies among jurisdictions.

Tribal communities have developed culturally grounded programs combining addiction medications, traditional healing, family support, naloxone, behavioral-health care, and locally designed prevention.

Veterans may face overlapping chronic pain, trauma, depression, alcohol misuse, opioid exposure, and suicide risk. Coordinated addiction and mental-health services are particularly important for these populations.

International programs also provide examples of comprehensive prevention. European countries have expanded take-home naloxone, syringe services, drug checking, supervised drug-consumption services, and infectious-disease prevention. International health guidance increasingly supports effective opioid-dependence treatment and community access to overdose-reversal medications.

Conclusion

The decline in overdose deaths provides evidence that prevention and treatment can save lives, but the drug-overdose crisis remains far from over. Tens of thousands of preventable deaths continue to occur, and rapidly changing supplies of fentanyl, carfentanil, xylazine, counterfeit pills, and multiple-drug combinations create continuing risks.

Naloxone is one of the most important immediate tools for reversing opioid overdoses. Wider distribution, community training, and rapid emergency response can prevent deaths. A successful overdose response should also create a direct pathway into evidence-based addiction treatment.

Methadone, buprenorphine, recovery services, mental-health care, harm reduction, surveillance, housing support, and peer programs all play important roles. Addiction cannot be effectively addressed through a single medication, policy, or law-enforcement strategy.

Long-term progress requires sustained funding, reliable public-health data, evidence-based treatment, community partnerships, and policies addressing poverty, housing instability, stigma, and unequal access to care.

Falling overdose mortality should be viewed as a reason to strengthen successful strategies rather than withdraw them. Maintaining momentum can transform temporary declines into a sustained reduction in addiction-related illness and preventable deaths.

• • TOC**

Overdose Trends and Mortality

Canada Reports Decline in Drug-Toxicity Deaths and Expands Federal Response

| Health Canada | Government of Canada | July 2026

Canadian officials reported a substantial decline in drug-toxicity deaths during 2025 while emphasizing that naloxone distribution, treatment, drug checking, surveillance, and community services remain necessary.

U.S. Overdose Deaths Fell Again in 2025

| Associated Press | STAT | May 13, 2026

Preliminary federal data estimated approximately 70,000 overdose deaths in 2025, representing the third consecutive annual decline but still leaving the country with an extraordinarily high and preventable death toll.

Drug Overdose Deaths Declined for a Third Consecutive Year

| Mike Stobbe | Associated Press | May 13, 2026

The United States recorded another decrease in overdose deaths during 2025, although researchers cautioned that changes in government policy, treatment availability, naloxone access, or the illicit drug supply could reverse the improvement.

Seventy-Two Thousand Annual Overdose Deaths Should Not Become Normal

| David A. Patterson Silver Wolf | STAT | March 9, 2026

Falling overdose numbers should not cause governments or the public to accept tens of thousands of preventable deaths as normal or withdraw funding before the crisis has been brought under control.

Overdose Deaths Continued Falling but at a Slower Rate

| Mike Stobbe | Associated Press | January 14, 2026

Provisional CDC figures showed overdose deaths declining through much of 2025, but the rate of improvement slowed and monthly deaths remained above levels recorded before the COVID-19 pandemic.

Federal Data Show Overdose Deaths Falling Through Most of 2025

| Associated Press | STAT | January 14, 2026

The longest sustained decline in overdose mortality in decades continued, but researchers warned that the progress remained fragile and unevenly distributed among states and communities.

CDC Reports Largest One-Year Drop in Overdose Deaths

| National Center for Health Statistics | CDC | May 14, 2025

Provisional federal figures showed overdose deaths dropping sharply during 2024, providing evidence that prevention, treatment, naloxone, settlement investments, and changes in the drug supply may be saving lives.

United States Records 27 Percent Decline in Overdose Deaths

| Mike Stobbe | Associated Press | May 14, 2025

Approximately 30,000 fewer people died from overdoses in 2024 than in 2023, producing the largest single-year decline recorded in national overdose data.

Drug Overdose Deaths Drop to Lowest Level Since 2019

| Lev Facher | STAT | May 14, 2025

Fentanyl-related deaths declined substantially during 2024, although methamphetamine, cocaine, regional inequalities, and continued exposure to synthetic opioids remained important public-health concerns.

CDC Reports Nearly 24 Percent Decline in Overdose Deaths

| Centers for Disease Control and Prevention | CDC | February 25, 2025

Provisional data predicted approximately 87,000 overdose deaths during the 12 months ending in September 2024, down from roughly 114,000 during the preceding period.

United States Overdose Deaths Begin a Rapid Reversal

| Mike Stobbe | Associated Press | November 13, 2024

National provisional data showed overdose mortality declining rapidly after years of increases, with researchers pointing to naloxone, treatment, outreach, reduced fentanyl exposure, and pandemic recovery as possible factors.

Understanding Drug Overdose Death Rates

| National Institute on Drug Abuse | National Institutes of Health | 2024

National charts document changing overdose mortality involving synthetic opioids, heroin, prescription opioids, cocaine, methamphetamine, benzodiazepines, and combinations of multiple substances.

Policy, Funding and Government Strategy

Federal Government Announces $281 Million for Addiction and Mental Health Programs

| Reuters | Reuters | July 6, 2026

The Department of Health and Human Services announced more than $281 million in grants for addiction treatment, overdose prevention, mental health care, recovery services, workforce development, trauma programs, and specialized training for first responders.

Federal Programs Ordered to Move Away from Some Overdose-Prevention Strategies

| Jessica Glenza | The Guardian | June 26, 2026

Federal health programs were directed to place less emphasis on certain harm-reduction approaches, raising concern among public-health specialists who believe naloxone, drug checking, and direct outreach contributed to falling overdose deaths.

National Drug-Control Strategy Emphasizes Prevention, Recovery and Public Safety

| Drug Free America Foundation | Drug Free America Foundation | May 27, 2026

The national strategy calls for prevention education, stronger recovery systems, expanded naloxone training, improved drug testing, treatment access, law enforcement coordination, and faster responses to emerging overdose clusters.

Federal Drug Strategy Promises Addiction Services Amid Funding Concerns

| KFF Health News | KFF Health News | May 6, 2026

The administration’s drug strategy endorses prevention, treatment, recovery, and naloxone while health-policy specialists question whether federal restructuring and funding reductions are compatible with those stated goals.

Federal Officials Restrict Funding for Test Strips and Syringe Services

| Lev Facher | STAT | April 27, 2026

New federal guidance limits the use of certain funds for fentanyl test strips and sterile syringes, marking a shift toward abstinence-focused policies and prompting objections from harm-reduction and addiction specialists.

Advocates Urge Continued Federal Investment in Overdose Prevention

| Overdose Prevention Initiative | Advocacy Incubator | April 16, 2026

Written testimony urged Congress to sustain funding for community prevention, treatment, recovery support, overdose response, behavioral-health workers, first responders, drug courts, and public-health data systems.

Organizations Call for Sustained Overdose-Prevention Appropriations

| Overdose Prevention Initiative | Advocacy Incubator | April 13, 2026

Public-health organizations warned that reductions in federal overdose funding could undermine recent gains and called for continued support for prevention, treatment, harm reduction, recovery, surveillance, and community-based programs.

Federal Cuts Could Undermine Alaska’s Response to Overdose Deaths

| The Guardian | The Guardian | December 15, 2025

Alaska faces geographic isolation, limited treatment capacity, high transportation costs, and increasing fentanyl deaths, while proposed federal cuts could weaken enforcement, Medicaid coverage, and community overdose programs.

Opioid Settlement Money Sometimes Pays for Questionable Expenses

| Aneri Pattani | KFF Health News | November 3, 2025

A national investigation found that some local governments used opioid-settlement money for law-enforcement equipment and routine expenses instead of concentrating the funds on addiction treatment, recovery, prevention, and overdose response.

Opioid Settlement Spending Database Reveals Local Priorities

| KFF Health News | KFF Health News | November 3, 2025

A searchable database provides thousands of examples showing how state and local governments are spending legal-settlement money intended to address the opioid crisis.

Administration’s Drug Strategy Mixes Enforcement and Treatment

| Lev Facher | STAT | April 3, 2025

An early federal drug-policy outline emphasized border enforcement and criminal penalties while also mentioning prevention, recovery, medications for addiction treatment, and naloxone.

Federal Health Reorganization Could Weaken Addiction Programs

| Amanda Seitz | Associated Press | March 28, 2025

Plans to absorb SAMHSA into a larger federal agency raised concern that addiction grants, crisis services, treatment programs, overdose prevention, and specialized expertise could lose visibility or funding.

Evidence-Based Drug Policy Is Essential During Political Change

| Samir Mitragotri and colleagues | National Library of Medicine | 2025

The authors argue that enforcement-focused approaches should not replace evidence-based prevention, treatment medications, naloxone, harm reduction, research, and policies addressing the health dimensions of addiction.

Communities Need Continued Funding for Addiction and Overdose Programs

| Partnership to End Addiction | Partnership to End Addiction | 2025

Advocacy organizations warn that cuts to federal health agencies, Medicaid, prevention grants, and behavioral-health services could reduce treatment access and reverse recent declines in overdose mortality.

Naloxone and Emergency Overdose Response

FDA Broadens Access to Over-the-Counter Naloxone Nasal Spray

| U.S. Food and Drug Administration | FDA | July 2, 2026

The FDA expanded over-the-counter access to another naloxone nasal spray as part of an effort to make opioid-overdose reversal medication easier to obtain in pharmacies, stores, community programs, and other public locations.

Over-the-Counter Naloxone Expands Access but Gaps Remain

| Ryu Kariyawasam-Chavez and Alison Newman | Pharmacy Times | June 26, 2026

Over-the-counter naloxone has made the overdose-reversal medication more visible, but price, pharmacy participation, insurance limitations, stigma, and unequal distribution continue to restrict access in many communities.

Kansas Permits Emergency Use of Expired Naloxone

| DCCCA | DCCCA | April 29, 2026

A Kansas law permits first responders and others to administer and distribute expired opioid antagonists when needed, helping prevent usable naloxone supplies from being discarded during an overdose emergency.

California Prisons Expand Access to Naloxone

| California Department of Corrections and Rehabilitation | Inside CDCR | March 24, 2026

California correctional facilities expanded naloxone availability for incarcerated people and staff as part of an effort to reduce fatal overdoses inside prisons and during the high-risk period following release.

Powerful Opioid Antidote Failed to Replace Naloxone

| Lev Facher | STAT | January 29, 2026

The more powerful overdose-reversal spray Opvee struggled to gain acceptance because advocates questioned its cost, necessity, and increased potential to trigger severe opioid withdrawal compared with standard naloxone.

Indiana’s Overdose Decline Shows the Value of Naloxone Investment

| Associated Press | AP News | June 2024

Indiana’s falling overdose deaths were linked to naloxone distribution, additional treatment capacity, settlement funding, recovery programs, and coordinated state and community action.

Higher-Dose Naloxone Did Not Produce Better Survival

| Mike Stobbe | Associated Press | February 8, 2024

A study found no survival advantage for an eight-milligram naloxone spray compared with the standard four-milligram dose, while the stronger product produced more withdrawal symptoms and vomiting.

Naloxone Can Reverse an Opioid Overdose

| National Institute on Drug Abuse | National Institutes of Health | 2024

Naloxone rapidly blocks opioid effects and can restore breathing during an overdose, but emergency assistance is still necessary because its effects may wear off before the opioids leave the body.

Recognizing the Signs of an Opioid Overdose

| Centers for Disease Control and Prevention | CDC | 2024

Warning signs include unconsciousness, slowed or stopped breathing, choking or gurgling sounds, limpness, discolored lips, and pinpoint pupils, requiring immediate naloxone administration and emergency assistance.

Overdose Survivors Need Rapid Follow-Up Care

| Centers for Disease Control and Prevention | CDC | 2024

A nonfatal overdose should trigger naloxone provision, assessment for substance-use disorder, medication initiation, mental-health screening, safety planning, and a direct connection to continuing treatment.

Family Members Can Learn to Administer Naloxone

| Substance Abuse and Mental Health Services Administration | SAMHSA | 2024

Families, friends, caregivers, service workers, and community members can be trained to recognize an opioid overdose, give naloxone, provide rescue breathing, and remain with the person until help arrives.

Good Samaritan Laws Encourage Emergency Calls

| National Conference of State Legislatures | NCSL | 2024

Many states provide limited legal protections for people who call emergency services during an overdose, although the scope of immunity and offenses covered varies among jurisdictions.

Naloxone Distribution Programs Place Medication in Communities

| California Department of Health Care Services | California Opioid Response | 2024

California supplies free naloxone to schools, libraries, community organizations, tribal groups, first responders, treatment providers, harm-reduction programs, shelters, and other eligible organizations.

Community Naloxone Cabinets Increase Public Access

| Remedy Alliance and Community Partners | Naloxone for All | 2024

Public naloxone boxes, vending machines, cabinets, and community distribution sites place overdose-reversal medication where it can be obtained anonymously and used immediately.

FDA Approves a Second Over-the-Counter Naloxone Product

| U.S. Food and Drug Administration | FDA | July 28, 2023

Approval of an additional nonprescription naloxone spray increased competition and created more opportunities for pharmacies, retailers, schools, workplaces, and community programs to stock overdose medication.

Over-the-Counter Narcan Represents a Major Access Change

| U.S. Food and Drug Administration | FDA | March 29, 2023

FDA approval of the first nonprescription naloxone nasal spray allowed the medication to be sold directly in stores and online without requiring an individual prescription.

Overdose Education Should Include Rescue Breathing

| National Harm Reduction Coalition | National Harm Reduction Coalition | 2023

Effective response includes checking for breathing, calling emergency services, giving naloxone, providing rescue breaths when appropriate, administering another dose if necessary, and remaining with the person.

Public Schools Are Beginning to Stock Naloxone

| U.S. Department of Education and Federal Partners | SchoolSafety.gov | 2023

School naloxone policies can prepare nurses, teachers, coaches, and other staff to recognize overdoses, administer medication, contact emergency services, and respond to fentanyl exposure among students or visitors.

Families Need Reliable Guidance After an Overdose

| Partnership to End Addiction | Partnership to End Addiction | 2023

Following a nonfatal overdose, families can obtain naloxone, discuss treatment without judgment, seek medical evaluation, remove immediate risks, establish an emergency plan, and connect the person with evidence-based care.

Naloxone Should Be Available Wherever Overdoses May Occur

| U.S. Department of Health and Human Services | HHS | 2023

Federal overdose guidance encourages individuals, families, first responders, service organizations, and businesses to keep naloxone available and learn how to respond to a suspected opioid overdose.

Addiction Treatment and Recovery

Natural Disasters Disrupt Addiction Treatment

| KFF Health News | KFF Health News | January 2026

Hurricanes, floods, wildfires, and other emergencies can interrupt access to methadone, buprenorphine, pharmacies, transportation, counseling, and communication, placing people with substance-use disorders at greater risk of relapse and overdose.

The Future of Addiction Medicine Remains Contested

| KFF Health News | KFF Health News | January 7, 2026

Disagreements over abstinence, medications, harm reduction, professional standards, and political oversight illustrate the continuing struggle over how addiction medicine should treat and support people who use drugs.

Medications Effectively Treat Opioid-Use Disorder

| National Institute on Drug Abuse | National Institutes of Health | 2024

Methadone, buprenorphine, and naltrexone are evidence-based treatments that can reduce opioid use, withdrawal, criminal activity, infectious-disease risk, and mortality when combined with appropriate medical and social support.

Buprenorphine Expands Treatment Options for Opioid Addiction

| Substance Abuse and Mental Health Services Administration | SAMHSA | 2024

Buprenorphine reduces cravings and withdrawal and can be prescribed in medical settings, increasing the possibility that people will receive addiction treatment outside traditional opioid-treatment programs.

Methadone Remains a Highly Effective Addiction Treatment

| Substance Abuse and Mental Health Services Administration | SAMHSA | 2024

Methadone stabilizes opioid receptors, reduces withdrawal and cravings, and substantially lowers mortality when patients can obtain consistent treatment through appropriately regulated programs.

Naltrexone Blocks the Effects of Opioids

| Substance Abuse and Mental Health Services Administration | SAMHSA | 2024

Naltrexone is a non-opioid medication that blocks opioid effects and can support recovery, although patients must complete opioid withdrawal before beginning treatment.

Treatment Locators Help Families Find Addiction Services

| Substance Abuse and Mental Health Services Administration | FindTreatment.gov | 2024

The federal treatment locator allows users to search for substance-use and mental-health services by location, payment options, treatment type, medications offered, age group, and accessibility.

Stigma Interferes with Addiction Treatment

| National Institute on Drug Abuse | National Institutes of Health | 2024

Stigmatizing language and discriminatory attitudes discourage people from seeking care, influence health professionals, encourage punitive policies, and obscure the fact that substance-use disorders are treatable medical conditions.

Recovery Support Extends Beyond Medical Treatment

| Substance Abuse and Mental Health Services Administration | SAMHSA | 2024

Long-term recovery may require housing, employment assistance, peer services, education, transportation, family support, health care, community connection, and protection from discrimination.

Peer-Support Workers Strengthen Addiction Services

| Substance Abuse and Mental Health Services Administration | SAMHSA | 2024

People with lived recovery experience can help others navigate treatment, remain engaged in services, build trust, establish goals, and connect with housing, employment, and community resources.

Opioid Treatment Should Continue During Pregnancy

| American College of Obstetricians and Gynecologists | ACOG | 2024

Medical guidance generally recommends methadone or buprenorphine during pregnancy rather than abrupt withdrawal, which can increase the risk of relapse, overdose, and pregnancy complications.

Adolescents with Opioid Addiction Need Evidence-Based Treatment

| National Institute on Drug Abuse | National Institutes of Health | 2024

Young people benefit from early screening, confidential care, family involvement when appropriate, overdose education, naloxone, mental-health support, and access to effective addiction medications.

Primary-Care Clinics Can Treat Substance-Use Disorders

| Substance Abuse and Mental Health Services Administration | SAMHSA | 2024

Integrating addiction treatment into primary care reduces barriers, enables earlier diagnosis, coordinates mental and physical health services, and allows patients to receive treatment in familiar medical settings.

Emergency Departments Can Begin Buprenorphine Treatment

| National Institute on Drug Abuse | National Institutes of Health | 2024

Starting buprenorphine after an overdose or during opioid withdrawal can reduce cravings and create an immediate pathway from emergency care into continuing addiction treatment.

Pain Treatment and Overdose Prevention Must Be Balanced

| Centers for Disease Control and Prevention | CDC | 2024

Clinicians should use individualized pain treatment, discuss benefits and risks, monitor potentially dangerous medication combinations, avoid abrupt discontinuation, and offer treatment when opioid-use disorder is identified.

Rural Communities Face Distinct Treatment Barriers

| Rural Health Information Hub | RHIhub | 2024

Rural residents may face long travel distances, workforce shortages, limited methadone programs, inadequate broadband, stigma, emergency-response delays, and fewer recovery-support services.

Telehealth Can Expand Addiction Treatment

| U.S. Department of Health and Human Services | Telehealth.HHS.gov | 2024

Telehealth can connect patients with counseling, buprenorphine prescribers, behavioral-health specialists, peer workers, and follow-up care, particularly in rural or underserved areas.

Addiction Treatment in Jails Can Prevent Deaths

| Bureau of Justice Assistance | U.S. Department of Justice | 2024

Programs linking criminal-justice systems with treatment, overdose education, naloxone, reentry planning, peer navigation, and medications can reduce repeated incarceration and post-release mortality.

Overdose Diversion Can Connect People to Treatment Instead of Jail

| Veronica M. White and Laura A. Albert | arXiv | November 9, 2023

Modeling suggests that overdose diversion, arrest diversion, and reentry case management can reduce deaths and social costs when programs successfully connect eligible people with effective treatment.

Addiction Is a Treatable Chronic Medical Condition

| National Institute on Drug Abuse | National Institutes of Health | 2023

Repeated drug exposure can alter brain circuits involved in reward, judgment, stress, and self-control, but behavioral therapies, medications, social support, and sustained care can support recovery.

Relapse Does Not Mean Treatment Has Failed

| National Institute on Drug Abuse | National Institutes of Health | 2023

Because addiction is chronic and relapse can occur, treatment plans may need adjustment rather than abandonment, much as treatment is modified for other recurring medical conditions.

Treatment Retention Reduces Overdose Mortality

| National Institute on Drug Abuse | National Institutes of Health | 2023

Treatment is more effective when it is readily available, sustained long enough, tailored to individual needs, integrated with medical care, and supported by housing, employment, and family services.

Contingency Management Helps Treat Stimulant Addiction

| National Institute on Drug Abuse | National Institutes of Health | 2023

Contingency-management programs provide structured incentives for treatment attendance or drug-negative tests and have strong evidence for treating methamphetamine and cocaine-use disorders.

Motivational Interviewing Can Encourage Treatment Engagement

| Substance Abuse and Mental Health Services Administration | SAMHSA | 2023

Motivational interviewing uses empathy, collaboration, reflective listening, and exploration of personal goals to help individuals resolve uncertainty about changing substance use.

Trauma-Informed Care Improves Addiction Services

| Substance Abuse and Mental Health Services Administration | SAMHSA | 2023

Trauma-informed programs recognize the prevalence of adverse experiences, avoid retraumatization, create emotional and physical safety, and integrate trauma treatment with substance-use services.

Co-Occurring Mental Illness and Addiction Require Integrated Treatment

| Substance Abuse and Mental Health Services Administration | SAMHSA | 2023

Treating mental illness and substance-use disorder together improves coordination and reduces the risk that one untreated condition will undermine progress with the other.

Suicide Risk Should Be Assessed During Addiction Treatment

| Substance Abuse and Mental Health Services Administration | SAMHSA | 2023

Substance use can increase impulsivity, hopelessness, isolation, and access to lethal drugs, making suicide screening and crisis planning essential parts of addiction care.

Communities Can Build Comprehensive Recovery-Oriented Systems

| Substance Abuse and Mental Health Services Administration | SAMHSA | 2023

Recovery-oriented systems coordinate clinical treatment with peer services, housing, education, employment, family support, transportation, legal assistance, and long-term community participation.

Harm Reduction and Safer-Use Strategies

Harm Reduction Becomes More Accepted at Music Festivals

| Liam McCollum | Associated Press | June 10, 2025

Music festivals are increasingly permitting nonprofit groups to distribute naloxone, provide overdose-response training, test drugs, and teach attendees how to reduce risks associated with contaminated substances.

Fentanyl Test Strips Can Reduce Accidental Exposure

| Centers for Disease Control and Prevention | CDC | 2024

Drug-checking strips can detect fentanyl in many substances, allowing people to take precautions, avoid using alone, carry naloxone, use a smaller amount, or decide not to consume a tested drug.

Syringe-Service Programs Connect People with Health Care

| Centers for Disease Control and Prevention | CDC | 2024

Syringe programs reduce infectious-disease transmission and can provide naloxone, testing, vaccinations, wound care, treatment referrals, sterile equipment, and trusted contact with health professionals.

Drug Checking Provides Information About the Illicit Supply

| National Institute of Standards and Technology | NIST | 2024

Laboratory and field-based drug analysis can identify fentanyl, xylazine, novel opioids, contaminants, and changing potency, supporting public warnings and more effective emergency responses.

Never Use Alone Services Provide Remote Overdose Monitoring

| Never Use Alone | Never Use Alone | 2023

Remote monitoring services allow a person to contact a trained operator before using drugs so emergency responders can be called when the person becomes unresponsive.

Drug Supply and Emerging Substance Risks

Carfentanil Reemerges as an Extremely Potent Threat

| Associated Press | AP News | April 18, 2026

Carfentanil, a synthetic opioid far more powerful than fentanyl, has reappeared in the illicit drug supply and caused hundreds of deaths, creating new challenges for drug checking, overdose recognition, and naloxone response.

Lower Fentanyl Potency May Help Explain Declining Deaths

| Lev Facher | STAT | January 8, 2026

Researchers proposed that lower fentanyl potency, precursor-chemical restrictions, expanded naloxone, treatment access, and changes in drug-use patterns may all have contributed to declining overdose mortality.

Fentanyl Seizures Decline Along the United States-Mexico Border

| The Washington Post | The Washington Post | May 31, 2025

A major decline in border fentanyl seizures generated debate over whether the illicit supply was shrinking, traffickers had changed tactics, or precursor restrictions and cartel conflicts were altering production.

World Drug Report Examines Global Drug Markets and Health Consequences

| United Nations Office on Drugs and Crime | United Nations | 2025

The World Drug Report reviews international drug production, trafficking, consumption, treatment access, overdose deaths, organized crime, emerging substances, and the health and social consequences of drug markets.

Fentanyl Is Frequently Mixed into Other Drugs

| Centers for Disease Control and Prevention | CDC | 2024

Illicit fentanyl may be present in heroin, cocaine, methamphetamine, and counterfeit pills, making it difficult for users to know the potency or contents of a substance.

Polysubstance Use Complicates Overdose Response

| National Institute on Drug Abuse | National Institutes of Health | 2024

Combining opioids with alcohol, benzodiazepines, stimulants, or other substances can increase overdose risk, produce unpredictable symptoms, and complicate emergency treatment.

Xylazine Creates Additional Health Risks in the Drug Supply

| National Institute on Drug Abuse | National Institutes of Health | 2024

Xylazine is increasingly detected with fentanyl and can cause profound sedation, slowed breathing, severe wounds, and overdose complications that naloxone alone may not completely reverse.

Counterfeit Pills Frequently Contain Illicit Fentanyl

| Drug Enforcement Administration | DEA | 2024

Counterfeit medications sold outside licensed pharmacies may resemble legitimate painkillers or anxiety medicines while containing unpredictable and potentially lethal quantities of fentanyl.

Cocaine Overdose Deaths Often Involve Fentanyl

| National Institute on Drug Abuse | National Institutes of Health | 2023

Cocaine can cause heart attack, stroke, seizures, and overheating, while contamination or combined use with fentanyl has contributed to a major rise in fatal overdoses.

Benzodiazepines Increase the Danger of Opioid Use

| National Institute on Drug Abuse | National Institutes of Health | 2023

Opioids and benzodiazepines both suppress breathing, making their combined use especially dangerous and requiring careful prescribing, patient education, naloxone access, and monitoring.

Alcohol and Opioids Can Produce Fatal Respiratory Depression

| National Institute on Alcohol Abuse and Alcoholism | National Institutes of Health | 2023

Alcohol can intensify the sedating effects of opioids and other depressants, increasing the likelihood of unconsciousness, vomiting, breathing failure, brain injury, and death.

Surveillance, Data and Early Warning

Social Conditions Help Identify Counties at Risk of Fentanyl Deaths

| Kabi Raj Tiruwa, Abhisan Ghimire and Anuj Kumar Shah | arXiv | May 6, 2026

Researchers found that disability, smoking, transportation limitations, health conditions, and inadequate treatment access could help identify counties vulnerable to fentanyl deaths before overdose mortality becomes more severe.

Anonymous Text Alerts Warn Residents About Dangerous Drug Supplies

| Associated Press | AP News | January 9, 2026

An Indianapolis text-alert program anonymously warns people who use drugs about fentanyl, pressed pills, unusual overdoses, contaminated supplies, and the need to carry naloxone and test substances.

Artificial Intelligence Could Improve Overdose-Death Surveillance

| Arthur J. Funnell and colleagues | arXiv | July 16, 2025

Researchers demonstrated that clinical language models can identify drugs mentioned in medical-examiner records, potentially making overdose surveillance faster and improving detection of emerging substances.

Research Uses Social-Media Language to Detect Opioid Risks

| Muhammad Ahmad and colleagues | arXiv | March 28, 2025

Researchers developed a system for recognizing opioid-related language in online discussions, with potential applications in surveillance, early warning, overdose detection, and understanding changing drug-use patterns.

Health Departments Can Improve Overdose Surveillance

| Centers for Disease Control and Prevention | CDC | 2024

CDC overdose data help public-health agencies identify substances involved in deaths, detect geographic disparities, follow emerging trends, and direct prevention resources to communities experiencing the greatest risk.

Overdose Mapping Can Detect Sudden Clusters

| Washington-Baltimore High Intensity Drug Trafficking Area | ODMAP | 2024

Real-time overdose mapping helps public-health and public-safety agencies identify unusual increases, share alerts, distribute naloxone, investigate dangerous supplies, and coordinate community outreach.

Wastewater Surveillance May Reveal Drug Trends

| National Institute on Drug Abuse | National Institutes of Health | 2024

Wastewater testing and other surveillance methods may provide early information about changing patterns of drug consumption before hospital, arrest, or mortality data become available.

Prevention and Safer Prescribing

Preventing Opioid Overdose Requires Multiple Strategies

| Centers for Disease Control and Prevention | CDC | 2024

Effective overdose prevention combines safer prescribing, early intervention, treatment medications, naloxone, harm reduction, surveillance, recovery support, public education, and policies addressing social and economic risks.

Prescription Drug Monitoring Programs Can Identify Risk

| Centers for Disease Control and Prevention | CDC | 2024

Monitoring databases can help clinicians identify overlapping prescriptions, dangerous medication combinations, multiple prescribers, and other patterns requiring careful review rather than automatic dismissal from care.

Safe Medication Storage Helps Prevent Accidental Poisoning

| U.S. Food and Drug Administration | FDA | 2024

Locking medications away from children and visitors and properly disposing of unused opioids can reduce accidental ingestion, diversion, misuse, and the circulation of leftover prescription drugs.

Drug Take-Back Programs Remove Unused Opioids from Homes

| Drug Enforcement Administration | DEA | 2024

Permanent collection locations and national take-back events allow households to dispose of unused controlled medications without placing them in household trash or leaving them accessible for misuse.

Social Conditions and Health Equity

Deleted Health-Equity Guidance Raised Overdose-Prevention Concerns

| Men’s Health | Men’s Health | 2025

Public-health specialists warned that removing federal information about housing, discrimination, trauma, employment, poverty, and other overdose risk factors could make evidence-based prevention more difficult.

Words Matter When Discussing Addiction

| National Institute on Drug Abuse | National Institutes of Health | 2024

Person-first language such as “person with a substance-use disorder” reduces stigma and avoids defining an individual by a medical condition or behavior.

Substance-Use Prevention Begins with Protective Environments

| Substance Abuse and Mental Health Services Administration | SAMHSA | 2024

Prevention programs can strengthen families, improve school climates, reduce trauma, delay initial substance use, increase social connection, and address community conditions that contribute to addiction.

Housing Instability Increases Overdose Vulnerability

| Centers for Disease Control and Prevention | CDC | 2024

Homelessness, unstable housing, isolation, poverty, trauma, lack of transportation, and limited health care can increase overdose risk and interfere with consistent addiction treatment.

Overdose Prevention Must Address Racial Disparities

| Centers for Disease Control and Prevention | CDC | 2023

Overdose mortality has risen disproportionately in some Black, American Indian, Alaska Native, rural, and economically marginalized communities, requiring culturally appropriate and locally led prevention strategies.

Populations and Community Settings

CDC Provides Evidence-Based Strategies to Prevent Youth Substance Use

| Centers for Disease Control and Prevention | CDC | August 15, 2025

The ENGAGE resource helps schools, families, health departments, and community organizations select interventions addressing youth risk factors, protective relationships, school environments, and early substance use.

Overdose Risk Increases Following Release from Incarceration

| National Institute on Drug Abuse | National Institutes of Health | 2024

Reduced opioid tolerance, treatment interruption, unstable housing, and limited medical care make the period after jail or prison particularly dangerous, supporting treatment initiation before release and continuity afterward.

Libraries Have Become Overdose-Prevention Partners

| WebJunction | OCLC | 2023

Libraries increasingly provide naloxone, staff training, social workers, treatment information, peer outreach, and safe connections to community services because they frequently serve people experiencing homelessness or addiction.

Workplaces Can Prepare for Opioid Overdoses

| National Institute for Occupational Safety and Health | CDC | 2023

Employers can establish naloxone policies, train staff, reduce injury-related opioid risks, support confidential treatment, and provide recovery-friendly employment practices.

Recovery-Friendly Workplaces Reduce Stigma

| U.S. Department of Labor | Recovery-Ready Workplace Resource Hub | 2023

Recovery-ready workplaces use nondiscriminatory policies, employee assistance, treatment referrals, supervisor education, second-chance hiring, and supportive return-to-work practices.

Tribal Communities Develop Culturally Grounded Recovery Programs

| Indian Health Service | IHS | 2023

Tribal responses combine medications, naloxone, traditional healing, family support, prevention education, behavioral-health care, and community-designed services addressing local needs.

Veterans Face Elevated Risks from Pain, Trauma and Substance Use

| U.S. Department of Veterans Affairs | VA Mental Health | 2023

Veterans may experience overlapping chronic pain, post-traumatic stress, depression, alcohol misuse, opioid exposure, and suicide risk, making coordinated mental-health and addiction treatment especially important.

General Overdose Prevention and Public Health

Rowan County Warns of Increase in Overdose Emergency Visits

| Rowan County Health Department | Rowan County Government | June 30, 2026

Rowan County health officials warned residents about increasing overdose-related emergency visits and a high rate of fentanyl-positive deaths while directing residents to naloxone, fentanyl test strips, treatment, and recovery services.

States Strengthen Partnerships to Prevent Drug Overdoses

| Clint Grant | Association of State and Territorial Health Officials | June 29, 2026

A multistate learning collaborative identified ways health departments can improve overdose prevention through partnerships, shared data, coordinated services, community engagement, and connections between public health and public safety agencies.

European Drug Report Reviews Harm-Reduction Services

| European Union Drugs Agency | European Drug Report | June 9, 2026

European countries have expanded take-home naloxone, supervised drug-consumption services, infectious-disease prevention, syringe programs, drug checking, and other interventions intended to reduce overdose deaths and health complications.

Mental-Health Conditions Frequently Appear in Overdose Death Investigations

| Centers for Disease Control and Prevention | CDC | May 27, 2026

CDC data show that many people who die from overdoses have evidence of a mental-health diagnosis or previous behavioral-health treatment, demonstrating the importance of integrating addiction and mental-health services.

CDC Outlines Public-Health Strategies for Preventing Overdose

| Centers for Disease Control and Prevention | CDC | May 6, 2026

CDC guidance encourages communities to combine surveillance, prevention, evidence-based treatment, harm reduction, public-safety partnerships, community outreach, and programs addressing social conditions associated with overdose risk.

WHO Updates Guidance on Opioid Dependence and Overdose Prevention

| Pan American Health Organization | PAHO and WHO | April 6, 2026

Updated international recommendations support effective opioid-dependence treatment and community management of overdose, including wider access to opioid agonist medicines and overdose-reversal medications.

SAMHSA Updates Overdose Prevention and Response Toolkit

| Substance Abuse and Mental Health Services Administration | SAMHSA | July 28, 2025

The updated toolkit explains overdose risk factors, recognition, emergency response, naloxone and nalmefene, rescue breathing, calling emergency services, post-overdose care, and ways communities can establish prevention programs.

Drug Overdoses Have Caused More Deaths Than the COVID-19 Pandemic

| Lev Facher | STAT | March 11, 2025

The cumulative overdose death toll illustrates the scale of the addiction crisis and the contrast between the emergency response to COVID-19 and the more fragmented response to drug-related deaths.

New York Operates a Statewide Overdose-Prevention Network

| New York State Department of Health | New York State | 2024

Registered community programs provide free overdose-recognition training and naloxone kits while connecting participants with treatment, harm reduction, recovery, and health services.

No FDA-Approved Medication Yet Exists for Stimulant-Use Disorder

| National Institute on Drug Abuse | National Institutes of Health | 2023

Methamphetamine addiction is generally treated with behavioral interventions and supportive care while researchers investigate medications and combinations that may reduce cravings and continued use.

Opioid Settlement Funds Should Supplement Existing Services

| Johns Hopkins Bloomberg School of Public Health | Principles for the Use of Funds from the Opioid Litigation | 2023

Public-health specialists recommend that settlement money be used to save lives, apply evidence, address racial and geographic inequalities, involve affected communities, and expand rather than replace existing funding.

Overdose Prevention Requires Maintaining Momentum

| Centers for Disease Control and Prevention | CDC | 2023

Declining deaths do not mean the overdose crisis has ended, and sustained progress depends on treatment access, naloxone, prevention, timely surveillance, public education, recovery support, and continued investment.